# reload+after+2024-01-21 13:40:13.116654
address1§Pencoed Business Park
city§Pencoed
zip§CF35 5HY
country§United Kingdom
phone§44 20 3819 8400
website§https://www.reneuron.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§ReNeuron Group plc researches, develops, and commercializes cell-based therapies in the United Kingdom. The company engages in the development of CTX stem cell therapy candidate for treating stroke disability; and human retinal progenitor cell therapy that is in Phase 2 clinical trial for treating retinitis pigmentosa, a blindness-causing disease. It also develops CTX-derived exosomes that are in the pre-clinical stage, which are Nano-sized vesicles secreted by stem cells. In addition, the company licenses ReNcell products. It has a collaboration agreement with University College London to conduct research into the generation of immune cells from induced pluripotent stem cells for anti-cancer cell therapies. The company was founded in 1997 and is headquartered in Pencoed, the United Kingdom.
fullTimeEmployees§26
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Iain Gladstone Ross B.Sc., BSc (Hons), C.DIR, CH.D', 'age': 69, 'title': 'Executive Chairman', 'yearBorn': 1954, 'fiscalYear': 2023, 'totalPay': 430000, 'exercisedValue': 0, 'unexercisedValue': 8050}, {'maxAge': 1, 'name': 'Mr. John Michael Hawkins A.C.A.', 'age': 56, 'title': 'Company Secretary, CFO & Director', 'yearBorn': 1967, 'fiscalYear': 2023, 'totalPay': 192908, 'exercisedValue': 0, 'unexercisedValue': 1610}, {'maxAge': 1, 'name': 'Dr. John David Sinden B.A., BA, M.A., MA, Ph.D.', 'age': 72, 'title': 'Co-Founder', 'yearBorn': 1951, 'fiscalYear': 2023, 'totalPay': 103000, 'exercisedValue': 0, 'unexercisedValue': 109138}, {'maxAge': 1, 'name': 'Ms. Suzanne  Hancock', 'title': 'Chief Operations Officer', 'fiscalYear': 2023, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Randolph  Corteling Ph.D.', 'title': 'Chief Scientific Officer', 'fiscalYear': 2023, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Simon  Dew', 'title': 'Chief Business Officer', 'fiscalYear': 2023, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1703980800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§0.967
priceToSalesTrailing12Months§11.704582
currency§GBp
forwardEps§7.2
exchange§LSE
quoteType§EQUITY
shortName§RENEURON GROUP PLC ORD 1P
longName§ReNeuron Group plc
firstTradeDateEpochUtc§1123830000
timeZoneFullName§Europe/London
timeZoneShortName§GMT
uuid§39e6ecc8-423f-39a2-9872-de40c8e0284c
recommendationMean§1.0
recommendationKey§strong_buy
quickRatio§1.507
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
